Cell Therapy News/Articles, page-10733

So my understanding here, from evaluating yourself and left-e, could be that this announcement in a way is a good thing, because at least the FDA are giving due consideration to a very serious illness that affects many, including children. So a prophylactic is a preventative to GVDH not a treatment once acquired, like Rem-L is? Again, this is like a covid vaccine against our treatment of severe ARDS being Rem-L, and so completely different, but ours probably more important at the saving from mortality end? Have I interpreted this correctly?